Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT03419156 Terminated - Clinical trials for Short Bowel Syndrome

Effect of a Short Message Service Intervention on Patients With Short Bowel Syndrome

Start date: February 20, 2018
Phase: N/A
Study type: Interventional

The investigators will be using a text messaging intervention to identify potentially dangerous and re- admission causing symptoms in patients with Short Bowel Syndrome (SBS) on Total Parenteral Nutrition (TPN). Each consented patient will receive weekly text messages inquiring about potentially harmful symptoms identified by a team of physicians. If the patient screens positive via text message, an alert will be sent to the medical team. All patients with SBS on TPN will receive text messages. The investigators will be monitoring response rates to text messages screening for potentially harmful symptoms and compare the text- message response rate to historical rates of successful calls by nurses. All patients with SBS on TPN will receive text messages instead of weekly phone calls from a nurse. If the patient does not respond to the text messages or the text message responses suggest that the patient may be presenting with potentially harmful symptoms, the nurse will call the patient to inquire about more information.

NCT ID: NCT03417973 Terminated - Pelvic Pain Clinical Trials

Quality of Life and Pain Changes Due to DRG Stimulation for Chronic Pain

ACTIVE
Start date: August 1, 2017
Phase:
Study type: Observational

ACTIVE study- a prospective observational clinical study examining the changes in quality of life and pain following dorsal root ganglion stimulation for the treatment of chronic intractable pelvic and lower limb pain.

NCT ID: NCT03417128 Active, not recruiting - Health Behavior Clinical Trials

Nutrition and Lifestyle Behaviour Peer Support Program Among Malaysian Adults With Metabolic Syndrome (PERSUADE)

PERSUADE
Start date: March 15, 2016
Phase: N/A
Study type: Interventional

The outlook of a community-based intervention targeting nutrition and lifestyle behaviour modification among adults with metabolic syndrome (MetS) has not been fully explored. The primary aim of this study (PERSUADE) is to evaluate the effect of the peer support intervention on the clinical outcomes MetS components followed by improvements in the participants' dietary practices, physical activity levels and lifestyle behaviours. The program constructed using information obtained from the published clinical and dietary guideline in Malaysia.

NCT ID: NCT03416647 Completed - Clinical trials for Superior Mesenteric Artery Syndrome

SMAS: a Prospective Study in a Single Institution

Start date: October 2008
Phase: N/A
Study type: Interventional

Superior Mesenteric Artery Syndrome (SMAS) is a rare cause of duodenal obstruction, that should be suspected in cases of chronic, refractory upper digestive symptoms. Between 2008 and 2016, 39 consecutive patients with chronic gastrointestinal symptoms and a diagnosis of SMAS were prospectively included in the study, in order to describe their demographic, clinical and outcome features. All patients underwent duodenojejunostomy.

NCT ID: NCT03415594 Completed - Clinical trials for Short Bowel Syndrome

Safety, Efficacy, PD of FE203799 in Short Bowel Syndrome on Parenteral Support

Start date: May 8, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Part A:once weekly dosing for 4 weeks in patients with short bowel syndrome who require total parenteral nutrition; patients will complete period 1 and after a 6-10 week wash-out, they will enter period 2 (active treatment and placebo); Part B: treatment period 3, is an open label extension to part A and starts after a washout of 6-10 weeks after the last dose in treatment period 2. patients are dosed once weekly for 4 weeks.

NCT ID: NCT03415529 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Impact of Arterial CO2 Tension on Management and Outcome in Patients With Acute Hypoxemic Respirator Failure and ARDS

CO2 LUNG SAFE
Start date: March 1, 2018
Phase:
Study type: Observational

There appears to be considerable variability in the approach physicians use to manage arterial carbon dioxide tensions, in patients in the early phases [first 48 hours] of ARDS (Acute hypoxemic respiratory failure and). A number of specific concerns exist, particularly the use of greater than needed inspired oxygen concentrations (potentially in 40% patients), and the proportion of hypocapnic patients in our cohort.

NCT ID: NCT03414996 Completed - Clinical trials for Acute Coronary Syndrome

High-intensity Interval Training in Patients With Post-acute Coronary Syndrome

EXIT-IV
Start date: January 1, 2011
Phase: N/A
Study type: Interventional

To date, no studies have evaluated the safety or efficiency (improvement of maximal oxygen uptake [VO2peak]) of a high-intensity interval training (HIIT) program in post-acute coronary syndrome (post-ACS) patients. Heart rate variability (HRV) and recovery (HRR), QT dispersion (QTd) and ventricular arrhythmias are all indices associated with an increased risk of cardiac death. HIIT has been shown to improve these risk markers and be safe in coronary heart disease patients but not yet in post-ACS patients which are considered more at risks. The aim of this study was to compare a HIIT program to a moderate-intensity continuous exercise training (MICET) program on HRV, HRR, QTd parameters and occurrence of ventricular arrhythmias in post-ACS patients.

NCT ID: NCT03414957 Completed - Metabolic Syndrome Clinical Trials

Malay Women With PCOS and Their Association With Metabolic Syndrome

MPMSS
Start date: November 2012
Phase:
Study type: Observational [Patient Registry]

The abnormalities that characterize the Metabolic Syndrome (MetS) confer an increased risk of cardiovascular and other diseases. Women with Polycystic Ovary Syndrome (PCOS), the commonest endocrine disease among women of childbearing age, have an increased risk of developing MetS. 2) The prevalence of MetS in PCOS patients varies among different ethnic groups. Malaysia is a unique country with a multiethnic population. The 3 largest ethnic groups are the Malays, Chinese and Indians. Previous studies in India and China have been able to determine the incidence of PCOS amongst those ethnic groups, but as yet, there is no published data on the prevalence of this disorder amongst women of Malay ethnicity. In this study, I intend to discover the prevalence of MetS amongst Malay women with established PCOS.

NCT ID: NCT03413488 Completed - Clinical trials for Shoulder Impingement Syndrome (SIS); Round Shoulder Posture (RSP)

Kinesio Taping Compared to Exercise Intervention for Round Shoulder Subjects With Impingement Syndrome

Start date: January 16, 2018
Phase: N/A
Study type: Interventional

To compare the effect between the exercise intervention (strengthening exercise and stretching exercise) and exercise intervention with taping on decreasing round shoulder posture and improving symptoms in subjects with shoulder impingement syndrome/round shoulder syndrome.

NCT ID: NCT03413423 Active, not recruiting - Clinical trials for Acute Coronary Syndrome

Post Acute Cardiac Event Smoking (PACES) Study

Start date: January 29, 2018
Phase: N/A
Study type: Interventional

Summary of the Project : Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). Objective: For this R01 the investigators will evaluate the efficacy of using a single, integrated treatment that targets both depressed mood and smoking (BAT-CS).